Stock Information
Exelixis Inc (EXEL)
Ticker Symbol: EXEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $12,600.43 mil
Piotroski score: 7
PE Ratio: 15.1189
EPS (TTM): 3.0172
Revenue (TTM): $8.89 M
Dividend Yield: N/A%
ROE: 40.21%
Latest News
-
Prediction: This Stock Could Double By 2031
Fri, May 15, 2026 11:50 PM
-
EXELIXIS INC (NASDAQ:EXEL) Presents a Compelling Case for Value Investors
Thu, May 14, 2026 11:00 AM
-
Exelixis, Inc. (EXEL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Tue, May 12, 2026 3:01 PM
-
Transcript : Exelixis, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Tue, May 12, 2026 2:05 PM
-
TD Cowen Sees Pipeline Growth Opportunities Supporting Exelixis, Inc. (EXEL) Outlook
Mon, May 11, 2026 8:01 PM
-
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May 2026
Mon, May 11, 2026 10:30 AM
Key Financials
Financial data not available
